PHARMACYTE BIOTECH INC's ticker is and the CUSIP is 71715X953. A total of 4 filers reported holding PHARMACYTE BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 200 | -99.7% | 0.00% | – |
| Q2 2023 | $188 | -33.1% | 65,800 | -32.0% | 0.00% | – |
| Q1 2023 | $281 | +87.3% | 96,800 | +88.0% | 0.00% | – |
| Q4 2022 | $150 | -100.0% | 51,500 | -80.6% | 0.00% | -100.0% |
| Q3 2022 | $636,000 | -2.5% | 265,000 | -9.0% | 0.00% | 0.0% |
| Q2 2022 | $652,000 | +65100.0% | 291,200 | +58140.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 300 | $630 | 0.00% |
| SIMPLEX TRADING, LLC | 200 | $0 | 0.00% |